Related Experiment Video
Updated: Jul 1, 2026

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Virologic Outcomes After LA ART Initiation with and without Viremia in Two Large U.S. Clinic Cohorts
Matthew Spinelli1, Megan J Heise1, David V Glidden1
1University of California, San Francisco, California, US.
Abstract:
Long-acting cabotegravir/rilpivirine supports virologic suppression among people with HIV (PWH) facing adherence challenges. In two large U.S. cohorts(n=1,070), 96% of viremic PWH achieved virologic suppression at a 4-week median. However, blips/failure were more frequent among PWH initiating with viremia, underscoring the need for careful monitoring and optimization of long-acting treatment.
Related Concept Videos
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Retrovirus Life Cycles
Retroviruses
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
